Woszczek G et al. |
IL-10 inhibits cysteinyl leukotriene-induced activation of human monocytes and monocyte-derived dendritic cells. |
2008 |
J. Immunol. |
pmid:18490762
|
Thivierge M et al. |
IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. |
2000 |
J. Immunol. |
pmid:11046055
|
Lee SP et al. |
Crosstalk between prostaglandin E2 and leukotriene B4 regulates phagocytosis in alveolar macrophages via combinatorial effects on cyclic AMP. |
2009 |
J. Immunol. |
pmid:19109185
|
Baker N et al. |
Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells. |
2009 |
J. Immunol. |
pmid:19265161
|
Chibana K et al. |
Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin. |
2003 |
J. Immunol. |
pmid:12682264
|
Boehmler AM et al. |
The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cells. |
2009 |
J. Immunol. |
pmid:19454674
|
Thivierge M et al. |
Cysteinyl-leukotriene receptor type 1 expression and function is down-regulated during monocyte-derived dendritic cell maturation with zymosan: involvement of IL-10 and prostaglandins. |
2009 |
J. Immunol. |
pmid:19846883
|
Papayianni A et al. |
Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. |
1996 |
J. Immunol. |
pmid:8690917
|
Cummings HE et al. |
Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor. |
2013 |
J. Immunol. |
pmid:24244016
|
Thivierge M et al. |
IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. |
2001 |
J. Immunol. |
pmid:11509632
|
Peres CM et al. |
Specific leukotriene receptors couple to distinct G proteins to effect stimulation of alveolar macrophage host defense functions. |
2007 |
J. Immunol. |
pmid:17911632
|
Prinz I et al. |
The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse alpha beta- and gamma delta effector T cells. |
2005 |
J. Immunol. |
pmid:16002666
|
Woszczek G et al. |
Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists. |
2010 |
J. Immunol. |
pmid:20083671
|
Dartt DA et al. |
Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. |
2011 |
J. Immunol. |
pmid:21357260
|
Davis HM et al. |
Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation. |
2000 |
J. Immunol. Methods |
pmid:10854607
|
Mayatepek E et al. |
Defects in the synthesis of cysteinyl leukotrienes: a new group of inborn errors of metabolism. |
2000 |
J. Inherit. Metab. Dis. |
pmid:10896305
|
Lee KH et al. |
Increased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria sera. |
2002 |
J. Invest. Dermatol. |
pmid:11918713
|
Klegeris A and McGeer PL |
Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP. |
2003 |
J. Leukoc. Biol. |
pmid:12629151
|
Spada CS et al. |
Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. |
1994 |
J. Leukoc. Biol. |
pmid:8301215
|
Krauss AH et al. |
Determination of leukotriene effects on human neutrophil chemotaxis in vitro by differential assessment of cell motility and polarity. |
1994 |
J. Leukoc. Biol. |
pmid:8301217
|